Stem cell therapy: Now the knee will be treated with stem cell therapy in the country, so much money will have to be paid for a vaccine
People suffering from knee problems in the country will now have the option of stem cell therapy along with complex treatment like knee replacement. Alkem Laboratories and Bengaluru-based biotech company Stemputix are going to commercialize StemOne, a stem cell therapy for the first time in India, to treat patients suffering from osteoarthritis, a type of arthritis. The cost of one vaccine is around Rs 1.25 lakh. In older patients of arthritis, the soft tissue that connects the bones in the knees is getting destroyed. The effect of this needle in them can last for two years or more. About 35 million people in India suffer from knee diseases. Currently, treatment options include non-steroidal anti-inflammatory drugs, hyaluronic acid vaccines, steroid vaccines, etc. The patient himself will be the donor in the treatment Alkem and Stemputix claim this is the first 'allogeneic cell' therapy product to be approved for commercial use for the treatment of osteoarthritis using stem...